BIO International Convention 2025, Boston
CLINEXEL participated in the BIO International Convention 2025, held in Boston from 16–19 June 2025.
The BIO International Convention is one of the world’s largest biotechnology gatherings, bringing together more than 20,000 leaders from the biotechnology, pharmaceutical, and life sciences sectors. The convention served as a global platform for collaboration, innovation, and strategic partnerships shaping the future of biotechnology.
During the event, the CLINEXEL team highlighted how its experts help accelerate biotech pipelines through:
- Patient-focused clinical trial design
- Strategic regulatory guidance
- High-quality clinical data analytics
These integrated capabilities support biotechnology and pharmaceutical companies in advancing innovative therapies from early development through successful clinical execution.
A key highlight of the convention was the opportunity to meet Kiran Mazumdar-Shaw, a pioneering leader in global biotechnology. Her presence at the India Pavilion and her message on strengthening biotech sovereignty and innovation in India inspired many participants and reinforced the growing global influence of India’s biotechnology ecosystem.
The CLINEXEL team also connected with Jitendra Kumar, Managing Director of Biotechnology Industry Research Assistance Council (BIRAC), discussing the importance of fostering:
- Innovation
- Investment
- Strategic collaborations
to support emerging biotechnology companies.
The convention provided an exceptional environment for:
- Networking
- Knowledge exchange
- Partnership development
reinforcing CLINEXEL’s commitment to supporting global biotechnology innovation through clinical development expertise, regulatory strategy, and patient-centric research approaches.